Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy (Q43513639)

24 November 2017

Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy (English)

1 reference

24 November 2017

7

1 reference

24 November 2017

Christopher Semsarian

10

object named as

Christopher Semsarian

1 reference

24 November 2017

1

Jodie Ingles

1 reference

24 November 2017

3

Laura Yeates

1 reference

24 November 2017

Tanya Sarina

2

1 reference

24 November 2017

Lauren Hunt

4

1 reference

24 November 2017

Ivan Macciocca

5

1 reference

24 November 2017

Louise McCormack

6

1 reference

24 November 2017

Julie McGaughran

8

1 reference

24 November 2017

John Atherton

9

1 reference

24 November 2017

language of work or name

English

0 references

publication date

18 April 2013

1 reference

24 November 2017

1 reference

24 November 2017

15

1 reference

24 November 2017

12

1 reference

24 November 2017

972-977

1 reference

https://scigraph.springernature.com/pub.10.1038/gim.2013.44

24 November 2017

0 references

cites work

The Genetic Basis for Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Sudden death in young athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Genetic basis of hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Establishment of an Australian National Genetic Heart Disease Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Guidelines for genetic testing of inherited cardiac disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Sudden cardiac death in familial hypertrophic cardiomyopathy: are "benign" mutations really benign?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Multiple mutations in genetic cardiovascular disease: a marker of disease severity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

7 January 2021

Yield of genetic testing in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

7 January 2021

Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

7 January 2021

Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

7 January 2021

The emerging role of the cardiac genetic counselor

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

7 January 2021

Prevention of sudden death for patients with cardiomyopathies another step forward

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2013.44

7 January 2021

Identifiers

DOI

10.1038/GIM.2013.44

1 reference

Dimensions Publication ID

24 November 2017

0 references

1 reference